Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Lipid Metabolism

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by extremely high low-density lipoprotein (LDL) cholesterol levels.
• Atherosclerosis is a major complication of FH, driven by lipid accumulation in artery walls.
• Reverse cholesterol transport (RCT) is a critical process for removing cholesterol from peripheral tissues.

Purpose of the Study:

• To investigate if impaired high-density lipoprotein (HDL) metabolism and RCT are inherent features of familial hypercholesterolemia (FH).
• To understand the role of low-density lipoprotein receptor (LDLR) dysfunction in RCT impairment in FH.

Main Methods:

• The study reviews existing literature on RCT and HDL metabolism in FH.
• Analysis focuses on mechanisms linking LDLR function, HDL levels, and cholesterol transport pathways.

Main Results:

• Macrophage RCT (m-RCT) is impaired in FH due to defective LDLR function, affecting both HDL- and LDL-mediated pathways.
• Impaired HDL metabolism, increased LDL levels, and defective LDL catabolism contribute to RCT dysfunction.
• RCT dysfunction is associated with mutation-positive FH, decreased HDL levels, and impaired HDL remodeling.

Conclusions:

• Impaired HDL metabolism and RCT are intrinsic features of FH, particularly in mutation-positive cases.
• Further research is needed to explore these alterations in uncharacterized FH forms and assess treatment efficacy.